Lates News

Adaptive Biotechnologies (ADPT.US): Revenue for Q1 2025 reached $52.4 million, up from $41.873 million in the previous quarter, and higher than the expected $42.13 million. Earnings per share were -$0.20, an improvement from the previous quarter's -$0.33, but slightly below the expected -$0.31.